Altered plasma protein profiles in genetic FTD - a GENFI study.

ABSTRACT:

Background

Plasma biomarkers reflecting the pathology of frontotemporal dementia would add significant value to clinical practice, to the design and implementation of treatment trials as well as our understanding of disease mechanisms. The aim of this study was to explore the levels of multiple plasma proteins in individuals from families with genetic frontotemporal dementia.

Methods

Blood samples from 693 participants in the GENetic Frontotemporal Dementia Initiative study were analysed using a multiplexed antibody array targeting 158 proteins.

Results

We found 13 elevated proteins in symptomatic mutation carriers, when comparing plasma levels from people diagnosed with genetic FTD to healthy non-mutation controls and 10 proteins that were elevated compared to presym

SUBMITTER: Ullgren A 

PROVIDER: S-EPMC10648335 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature